drugset / Trial / NCT05363644

BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy

NCT05363644 ↗

NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to assess functional outcomes post operatively after the use of BioDFence® G3 during robotic radical prostatectomy.

Timeline

Start
2023-04-01
Primary completion
2023-12-31
Completion
2024-06-30

Outcome

Outcome not reported

Stopped (Business): “Study was withdrawn due to lack of funding”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject BioDFence G3 Unknown — Other

Indications